The Austin-based startup will test its high-bandwidth device to help restore speech in people with extremely limited movement.
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
By combining LED technology and nanomaterials, researchers have created a therapy that eliminates cancer cells using localized heat without damaging healthy tissue.
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of editing human embryos to make disease-free children.
California-based Cognixion is launching a clinical trial to allow paralyzed patients with speech disorders the ability to communicate without an invasive brain implant.
Mindstate Design Labs, backed by Silicon Valley power players, has created what its CEO calls “the least psychedelic psychedelic that’s psychoactive.”
Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced insulin for months without the patient needing to take immunosuppressants.
Speaking at a WIRED event Tuesday, Moderna CEO Stéphane Bancel said he was “encouraged” by the company’s dialogue with the FDA—but acknowledged recent setbacks.
The brain implant company cofounded by Elon Musk filed to trademark the product names Telepathy and Telekinesis. But it turns out that another person had already filed to trademark those names.
A new policy document outlines China’s plan to create an internationally competitive BCI industry within five years, and proposes developing devices for both health and consumer uses.